|
| |
| | | 67681 | | 24.08.2020 | | NOBEL Pharma Schweiz AG | | | | | | | | | | | | | 06.99. | | | | 06.99. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Deferasirox NOBEL 90 mg | Filmtabletten | Filmtabletten (Deferasiroxum 90 mg) | V03AC03 | PI | | 02 | Deferasirox NOBEL 180 mg | Filmtabletten | Filmtabletten (Deferasiroxum 180 mg) | V03AC03 | | | 03 | Deferasirox NOBEL 360 mg | Filmtabletten | Filmtabletten (Deferasiroxum 360 mg) | V03AC03 | |
|
|
|
